The board of directors of biopharmaceutical company Pfizer Inc (NYSE:PFE) declared the company's 321st consecutive dividend of USD0.36 of its common stock for the first quarter 2019, it reported on Friday.
This new dividend marks a growth of approximately 6% from the prior dividend of USD0.34 per share of its common stock.
Shareholders of record at the close of business as of 1 February 2019 will receive the dividend on 1 March 2019,
Additionally, the board of directors has launched a new USD10bn share repurchase programme,which is in addition to the USD4.9bn remaining under its current authorisation.
C-Rad posts increased result in Q4 2018
Regeneron posts higher GAAP net income of USD2.444bn for 2018
Lannett announces record net sales of USD193.7m in Q2 fiscal 2019; increases fiscal 2019 outlook
Coloplast's profit up by 5% in Q1 2018/19
Neurocrine Biosciences achieves higher net income of USD21.1m for 2018
Stellar Biotechnologies incurs Q1 net loss of USD1.41m
Gilead Sciences reports 11% rise in Q1 2019 dividend
Senseonics extends distribution agreement with Roche Diabetes Care
Orexo reports financial results for Q4 2018
AstraZeneca reports completion of divestment of US Synagis rights to Sobi